Pharmafile Logo
Pharmafocus logo
Advanced Search
Praluent

Sanofi and Regeneron given European nod for Praluent

September 28, 2015
Sales and Marketing European Commission, Regeneron, Sanofi, alirocumab, high cholesterol, marketing authorisation, praluent

The European Commission (EC) has approved the marketing authorisation of Sanofi and Regeneron’s cholesterol drug Praluent.  The heart drug is …

News
Novo Nordisk building

FDA approves Novo Nordisk’s diabetes drugs

September 28, 2015
Sales and Marketing FDA, Novo Nordisk, Ryzodeg, Tresiba, diabetes, insulin

The FDA has approved two Novo Nordisk drugs, Tresiba and Ryzodeg, for the treatment of type 2 diabetes in adults.The …

News
Sanofi reception

Brandicourt set to continue Sanofi restructure

September 28, 2015
Sales and Marketing Merial, Sanofi, olivier brandicourt, restructuring, sales, spin-off

Sanofi chief executive Olivier Brandicourt is considering sales or spin-offs of a number of the company’s divisions, as part of …

News
law

Legal analysis: compliance top of the agenda for big pharma

September 25, 2015
Medical Communications, Sales and Marketing lawyers, legal, pharma industry, reputation

Do you think big pharma suffers from a negative image, and if so, to what extent do you think this …

Feature

Synergy Vision shortlisted for Women of the Future awards

September 25, 2015
Medical Communications Synergy Vision, medical communications, medical communications agency, women, women of the future awards

Synergy Vision has been shortlisted for the Women of the Future (“WOF”) Awards, the movement recognising and nurturing young female …

News
Press release
glioblastoma

ImmunoCellular awarded $19.9 million grant for ICT-107 phase 3 trial for glioblastoma

September 25, 2015
Research and Development California Institute for Regenerative Medicine, Cancer, ICT-107, brain cancer, glioblastoma

ImmunoCellular Therapeutics has been awarded a $19.9 million grant by California Institute for Regenerative Medicine (CIRM), California’s stem cell agency, …

News

Novartis’ new heart failure medicine recommended for EU approval

September 25, 2015
Medical Communications, Research and Development Entresto, Novartis, eams, heart failure

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Novartis’s heart failure medication Entresto …

News
velocity_health

Merck and Wayra to tackle NHS funding gap with startup rewards programme

September 25, 2015
Research and Development MSD, Merck

Merck Sharpe and Dohme (MSD) and Wayra Open Future, Telefonica’s digital start up accelerator, are investing in digital innovation in …

News
abpi_acting_ceo_alison_clough

ABPI responds to UK medicines cost controversy

September 25, 2015
Medical Communications, Sales and Marketing ABPI, Cancer Drugs Fund, NHS

Alison Clough, acting CEO of the Association of the British Pharmaceutical Industry (ABPI), has responded to recent reports in the …

News
copd

Genetic study reveals new associations with lung disease and smoking behaviour

September 25, 2015
Medical Communications, Research and Development COPD, lung cancer, smkoing

New research published in The Lancet Respiratory Medicine and presented at this year’s European Respiratory Society (ERS) Congress in Amsterdam …

News
novartis_access_ncds_facts

Novartis launches affordable medicines portfolio for lower-income countries

September 24, 2015
Manufacturing and Production, Sales and Marketing Novartis

Novartis has announced the launch of ‘Novartis Access’, a portfolio of 15 medicines to treat chronic diseases in low and …

News
gilead-sciences

NICE approves first in new class of leukaemia drugs

September 24, 2015
Cancer Drugs Fund, Gilead Sciences, NHS, NICE, idelalisib, leukaemia, zydelig

NICE has issued final draft guidance which recommends that Gilead’s Zydelig should be made available on the NHS for some …

News
turing_pharma

Turing will drop price of Daraprim following outrage

September 24, 2015
Sales and Marketing Daraprim, Impax Laboratories, Martin Shkreli, Turing Pharmaceuticals, toxoplasmosis

Martin Shkreli, whose company Turing Pharmaceuticals increased the price of Daraprim more than fifty-fold overnight, has been forced to backpedal …

News
BI building

Boehringer and BioMed X crowdsource top scientists to fight COPD

September 23, 2015
Research and Development Boehringer Ingelheim, COPD

Boehringer Ingelheim and BioMed X have used a crowdsourcing strategy to establish a global research team to collaborate on the …

News
HIV infected cell

ViiV in late-stage HIV trial success

September 23, 2015
Research and Development HIV, Triumeq, ViiV, virology

Switching patients to Triumeq, a once-daily combination treatment for HIV, is as effective as remaining on antiretroviral therapy in certain …

News

Pharma ‘is getting better at drug R&D’

September 23, 2015
Research and Development R&D, drug development, market access, productivity

An investigation into pharma R&D data shows that drugmakers are becoming more successful at identifying the right candidates for drug …

News
nn_flag

Novo Nordisk to build manufacturing plant for FlexPen in Iran

September 22, 2015
Manufacturing and Production Iran, Novo Nordisk, diabetes

Novo Nordisk has announced that Novo Nordisk Iran and the Food and Drug Administration of the Islamic Republic of Iran …

News
martin_shkreli

Anger as drug price rises from $13.50 to $750 overnight

September 22, 2015
Manufacturing and Production, Sales and Marketing pyrimethamine, turing

Turing founder Martin Shkreli has been forced to defend the company’s decision to raise the price of the drug Daraprim …

News
scottish_highlands

Vision for hi-tech manufacturing in the Scottish highlands

September 22, 2015
Manufacturing and Production, Research and Development GSK, Scotland, manufacturing

Scottish life and chemical science firms claim Scotland is an ideal European base for UK and global manufacturers. A new …

News
Zoloft

Pfizer and GSK in antidepressant safety probes

September 22, 2015
Manufacturing and Production GSK, Paxil, Pfizer, Zoloft, antidepressants, drug safety, paroxetine, sertraline

Two top-selling antidepressants have had their safety records challenges, after the FDA asked Pfizer to change the labelling of its …

News
The Gateway to Local Adoption Series

Latest content

Study explores genomic testing approach for unexplained infertility

May 14, 2026

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026

Synnovis and SOPHiA GENETICS expand liquid biopsy testing in NHS cancer care

May 13, 2026

MHRA to establish Northern Ireland hub for life sciences sector

May 13, 2026

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026